April 5, 2022 12:13 PM EDT
Pharma
Marketing

Mar­ket­ingRx roundup: Mer­ck re­ups HPV ads for young adults; Idor­sia study con­firms lit­tle sleep for weary

Beth Snyder Bulik

Senior Editor

Mer­ck is dou­bling down with new Gar­dasil 9 hu­man pa­pil­lo­mavirus vac­cine mes­sag­ing for young adults. A new TV com­mer­cial ex­tends its ef­forts, be­gun last year …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

A service from the Financial Times